ÇÄÇÄ»° Íøµê ºÃÓÑ ÐÅÏ¢ Ìû×Ó¼¯ תÕÊ ÒýÓà »Ø¸´ ²©¿Í ²¿Âä ÊÕ²Ø	¾«¼ò°æ Â¥Ö÷

(Òѽ±)¡¾ÂýËÙVOA¡¿£²£°£°£¸£­£°£µ£­£°£² New Malaria Drug Launched in Latin America, Southeast Asia¡¡(2/2) ( ±¾´ÎÌýдԼ191´Ê ) [ÏÂÔؽñÈÕÂýËÙVOAÌýÁ¦×ÊÁÏmp3°æ] (ÓÒ¼üÁí´æΪ) ¡¡ ¡öµã»÷²é¿´ÌýÁ¦´ð°¸¡ö ½«ÒôƵÖеÄÄÚÈÝÌýдÏÂÀ´£¬²¢½«ÄãµÄÌýд¸å»Ø¸´ÔÚ´ËÌûÖУ¬¼´¿É»ñµÃ´ð°¸£º£©»¶Ó­ÈÏÕæ²ÎÓëÌýд£¬ºÍ´ó¼Ò¹²Í¬½ø²½£¡¿É²»Òª¹àˮŶ£¡ Ìýд´ð°¸À´×Ô´ó¼ÒµÄÌýд¸å£¬Ã»ÓÐȨÍþ´ð°¸£¬»¶Ó­Ö¸³ö´íÎó^_^ Researchers tested the new medicine in a one-year study of seventeen thousand patients in the state of Acre in the Brazilian Amazon. Health care resources in the area were also expanded, including early identification of malaria. Health officials say the result was a thirty-six percent drop in cases. Malaria is caused by a parasite which is passed to humans through mosquito bites. As many as five hundred million infections happen every year. Around sixty percent of the cases, and more than eighty percent of the deaths, happen in Africa south of the Sahara. Africa suffers more than a million deaths, mostly children. Doctor Pecoul says his organization is supporting a study in Tanzania to see if the new drug could be used successfully in Africa. Currently in Africa, there are two first-line treatments with artesunate and other drugs. He says artesunate and mefloquine could have a use in places like eastern Africa where there are high levels of resistance to several drugs. The Drugs for Neglected Diseases Initiative began in two thousand three. It was established by the Pasteur Institute and Doctors Without Borders along with four publicly supported research organizations. Ìýд֮ºó£¬±ðÍüÁ˵½ÒëÎÄÓë×ܽáÌûºÍ´ó¼ÒÒ»ÆðÌÖÂÛŶ^_^ ¡öÒþ²Ø¡ö ѧϰ¸ü¶à£º ÂýËÙVOAÿÈÕÌýд£¨ÍùÆÚ»ã×Ü£¬3ÌìÇ°µÄ²ÄÁϴ𰸾ùÒѹ«²¼£© ³«ÒéÊ飺 ¡¾VOA°æ³«ÒéÊé¡¿ÈÏÕæÌýд£¬¾Ü¾ø¹àË®¿´´ð°¸ Ïà¹ØÁ´½Ó£º VOA This is America »¦½­ÂÛ̳ÌýÁ¦Ìá¸ßÓë½»Á÷·Ïßͼ VOAÌýÁ¦Á·Ï°Ïà¹Ø×ÊÔ´ VOAÖм¶ÃÀÓï(»ù´¡Æª) ÒѾ­½±Àø air19890520,alivehunter,angal,avenger07,barret,belle_ss,benjamin_xu,bluesky87,Boaz2,bood,cafeapril,calin3333,carl_wang,carmen4422,carol_guo,chenweibnu,cherry112233,CherryPeng,chneck,continuo,crime_mind,cryosoul,cwh67,cynthiabai,Darcy131,dfa1987,dori928,doyofyzj,Dream_Wing,dyf502,echo0902,echotsin,elysion,Emily_feifei,evebamboo,fayewongbk,fengco,fireflash,fishfresh,flowerjulie,fu_fu330,fuzhongyu,gaojie_hong,garfield3797,geraets87,gigiliu,googlecom2,guoguoshu,gzluo,hanlu8,heima8,helly_smile,hisoka,hmweepy,hotspot7064,huafar,huanghuayuzy,huihuiandli,huseatone,i_wanna,irlene23,jackmgheart,jane_9,jennifer_jjy,jibenren2,jiejietree,jqqsyy1989,junioryoyo,jy0347,keith_Dong,laosier,lhchit,li771220,liangxh127,linju,litewei,little_mouse,lolita00417,Lothlorien21,luffy27,lulud_1215,lxcool566,maoyu_roj,merlini,mexm2wh,micoeng,niningwuhen,nnngu,novice,nzxin0908,oulby,PANRICO,perua,pooq,poppy236,prettylxh,pu111even,purcell_yan,rainbow0203,rb19900,redhhy,rj5626,roxanne86022,shang8255,shelly_lcy,shuiiying,smqbianlian,snow_Z,songsongsuu,songyy,sscrystal,star_lulu,straightman,sweetashi,sydeny001,sykora,szhangxp,tangmm1010,tears919,tingyutan,tomatofreerh,tt3044,tttmp,tuzi_123,urbanity,vickyèè,viviwong,wangyi217,wendylwy,williamasten,wincu,windheaven,windowslid,wjwfrank,xcdd,xieyeld,xiongxiaof,xuyehui,xuzhen66,yanglei521,ycworld,yeatsgg,ygclwhl,yiliangyy,yingruoying,zhanglixing,zhuyiminzhuy,zjsxyxp,zulo2008,°¢M,±ÈÀûʱ,²¶µû,³ÌÔ¶CY,´ó±¦123,¶¡Ð¡Äª,·ç»¨½£ÔÂ,ºÚµÆÎèÅ£,¿ñ°®Mika,Á³Á³ÖÜ,›ö,·¹ýÕß,ĽÈÝ»ª»ª,Å£Èâ¸É¸É,Ƽ352,óÏ,æ­çÍ,ËÄÔÂÒîÈÕ,ÌÒ֮СÑý,Í»ÆÆ¿ÚÓï,ÍÅÍÅôÕ,ÎÄÏȽø,ÎʵÀÇà³Çɽ,ÎÞµÐСÏòÈÕ,ÎÞÀ±²»»¶,Ðý·çÖíÖí,ÓÆÓÆÐÄÇé,ÓôÓôÁÖÁÖ,×ÓÏ£,í§Òâ,×óñÅÐùÖ÷ µ¥¸öÓû§²Ù×÷£º½ðÇ®50 [´ËÌù×ÓÒѾ­±»×÷ÕßÓÚ2008-5-11 11:57:59±à¼­¹ý]

----------------------------------------------

ÇÄÇÄ»° Íøµê ºÃÓÑ ÐÅÏ¢ Ìû×Ó¼¯ תÕÊ QQ ÒýÓà »Ø¸´ ²©¿Í ²¿Âä ÊÕ²Ø	µÚ2Â¥¡ø

¡¾Ê¿±øÍ»»÷Ðж¯--Èý¶à273ºÅ¡¿ Researchers tested the new medicine in a one-year study of seventeen thousand patients in the state of A in the Brazilian artemisinin. Health care results in the area were also expanded inclouding early identification of malaria. Health officials say the result was a thirty-six percent drop in cases. Malaria is caused by a parasite which is passed to humans through the s buys. As many as five hundred million infactions happen every year. Around sixty percent of the cases and more than eighty percent of the death happen in Africa South of the S. Africa suffers more than a million deaths mostly children. Bernard Pecoul says his organization is supporting a study in Tanzania to see if the new drug could be successfully used in Africa. Crackly in Africa there are two first line treatments with artesunate and other drugs. He says artesunate and mefloquine could have a use in places like Eastern Africa where there are high levels of ? systems to several drugs. The Drugs for Neglected Diseases Initiative began in two thousand three. It was established by the pester institute and doctors without boaters along with four publicly supported research organizations. Ò»¼¤¶¯¡£¡£Ñ§ºÅÍü¼ÇÁË¡£¡£ [´ËÌù×ÓÒѾ­±»×÷ÕßÓÚ2008-5-2 5:05:12±à¼­¹ý]

----------------------------------------------

ÇÄÇÄ»° Íøµê ºÃÓÑ ÐÅÏ¢ Ìû×Ó¼¯ תÕÊ QQ ÒýÓà »Ø¸´ ²©¿Í ²¿Âä ÊÕ²Ø	µÚ3Â¥¡ø

¡¾Ê¿±øÍ»»÷Ðж¯¡ª¡ªÈý¶à051ºÅ¡¿ Researchers tested the new medicine in a one-year study of seventeen thousand patients in the state of Acry in the Brazilian Amazon. Health care resources in the area were also expanded, including early identification of malaria. Health officials say the result was a thirty-six percent drop in cases. Malaria is caused by a parasite which is passed to humans though mosquito bites. As many as five hundred million infections happen every year. Around sixty percent of the cases and more than eighty percent of the deaths happen in Africa south of the Sahara. Africa suffers more than a million deaths, mostly children. D* P* says his organization is supporting a study in Tanzania to see if the new drug could be used successfully in Africa. Currently in Africa, there are two first line treatments with ** and other drugs. He says ** and ** could have a use in places like eastern Africa where there are high levels of resistance to several drugs. The Drugs for Neglected Diseases Initiative began in two thousand three. It was established by the P* Institute and doctors without borders along with four publicly supported research organizations.

----------------------------------------------

ÇÄÇÄ»° Íøµê ºÃÓÑ ÐÅÏ¢ Ìû×Ó¼¯ תÕÊ ÒýÓà »Ø¸´ ²¿Âä ÊÕ²Ø	µÚ4Â¥¡ø

Researchers tested the new medicine in a one-year study of 17,000 patients in the state of A* in the Bralin* of Africa. Health care resources in the area were also expanded, including early identification of malaria. Health officials say the result was 30% drop in cases. Malaria is caused by a parasite, which is passed to humans through mosquito bites. As many as 500 million infections happen every year. Around 60% of cases and 80% of death happen in Africa, south of sahara*. Africa suffers more than a million death, mostly children. B* says his organization is supporting a study in T* to see if the new drug could be successfully used in Africa. Currently in Africa there are two first line treatments when they tested it* and other drugs. He say a tesernate* could have a use based like eastern Africa where there a high level of resistance to several drugs. The drugs * began in 2003. It was established by the P*paster Institute and doctors without borders along with four publicly supported

---------------------------------------------- Only your best will do.                      Hu-sea-tone

ÇÄÇÄ»° Íøµê ºÃÓÑ ÐÅÏ¢ Ìû×Ó¼¯ תÕÊ QQ ÒýÓà »Ø¸´ ²©¿Í ²¿Âä ÊÕ²Ø	µÚ5Â¥¡ø

Researchers tested the new medicine in a one-year study of 17000 patients in the state of A in the Brazilian A. Healthcare resources in the area were also expanded including early identification of malaria. Health officials say the result was a 36% drop in cases. Malaria is caused by a parasite which is past to humans through mesquite bites. As many as 500 million infections happen every year. Around 60% of the cases and more 80% of the deaths happen in Africa south of the Sahara. Africa suffers more than a million deaths mostly children. D says his organization is supporting a study in T to see if the new drug could be successfully used in Africa. C in Africa there are two fist line treatments where are t and other drugs. He says I and m could have a use in places like eastern Africa where there are high levels of resistance to several drugs. The drugs for neglected diseases initiative began in 2003. It will established by the pastor institute and doctors without borders along with four publicly supported research organization.

----------------------------------------------

ÇÄÇÄ»° Íøµê ºÃÓÑ ÐÅÏ¢ Ìû×Ó¼¯ תÕÊ QQ ÒýÓà »Ø¸´ ²©¿Í ²¿Âä ÊÕ²Ø	µÚ6Â¥¡ø

No.65 Researchers tested the new medicine in a one-year study of seventeen thousand patients in the state of arcu in the Bazillian amazon. Health care resources in the areas were also expended including early identification of malaria. Health officials say the result was a sixty percent drop in cases. Malaria is caused by a parasite which is pass to human through mosquito bites. As many as five hundred million infections happen every year. Around sixty percent of the cases and more than eighty percent of the death happen in Arican ,south of Saharra. Africa suffers more than a billion death mostly chilren. B P says his organization is supporting a study in Tanzania to see if the new drug could be successfully used in Africa. Currently in Africa ,there are two first line treatments with P and other drugs. He says pacenat and malaquen could help a use in places like Eastern Europe where there are high levels of resistance to several drugs. The drugs for negaletive disease and initiative began in 2003. It was establised by the Paster Institute and Doctors without Borders along with four publicly supported research organizations

----------------------------------------------

ÇÄÇÄ»° Íøµê ºÃÓÑ ÐÅÏ¢ Ìû×Ó¼¯ תÕÊ ÒýÓà »Ø¸´ ²©¿Í ²¿Âä ÊÕ²Ø	µÚ7Â¥¡ø

5-2 Researchers tested the new medicine in a one year study of 17000 patients in the state of A~ in Brazilian Amazone. Health care resources in the area were also expended including early identification of Malaria. EF say the result was a 36% drop in cases. Malaria is caused by a parasite which is passed to humans through mosquito bite. As many as 500 millian infections happen every year, around 60% of the cases and more than 80% of the death happen in Africa , south of the Sahara. Africa suffers more than 1 million death, mostly children. Doctor P~ says his organization is supporting a study in Tanzania to see if the new drug could be successfully used in Africa. ~ in Africa, there are two first lieing treatments which are Artesinate and other drugs. He says artesinate and mefloquine could have a use in palces like eastern Africa where there are high levels of resistence to sevel drugs. The drug for neglected diseases initiative began in 2003. It was established by the ~~ institute and doctors without borders along with four publicly supported research organizations.

ÇÄÇÄ»° Íøµê ºÃÓÑ ÐÅÏ¢ Ìû×Ó¼¯ תÕÊ ÒýÓà »Ø¸´ ²¿Âä ÊÕ²Ø	µÚ8Â¥¡ø

Researchers tested the new medicine in the one year studies of seventeen thousand patients int the state of Arque in the Brazilian Amerza.Health care resource in the area were also expended,including early identificiation of malaria.Health official say the result was thirty six percent drop in cases.Malaria is cost wide a parisite which is past to humans from the mosquito bites.As many as five hundred million infections happen every year.Around sixty percent of the cases and the more than eighty percent of death happen in Africa south of Sahara.African suffers more than million death mostly children.DukPagu says his organization is supporting a study in Tansania to see if the new drug could be successfully used in Africa.Currently in Africa there are two first line treatment _ and other drugs.He says _ and _ could have a use in places like Eastern Africa where there are high levels of resistance to severaldrugs.The drugs for neglected diseases initiative began in 2003. It was eastablished by the paster instituted and doctor without borders along with four publicly supported research organizations.

ÇÄÇÄ»° Íøµê ºÃÓÑ ÐÅÏ¢ Ìû×Ó¼¯ תÕÊ ÒýÓà »Ø¸´ ²©¿Í ²¿Âä ÊÕ²Ø	µÚ9Â¥¡ø

080502¡¾Èý¶à114ºÅ¡¿ Researchers tested the new medicine in a one-year study of 17,000 patients in the state of * in the Brazilian, Amazon. Health care resources in the area were also expanded including early identification of malaria. Health officials say the result was a 36% drug in cases. Malaria is caused wide apparent site which is passed to humans through mosquito bites. As many as 500 million infections happen every year. Around 60% of the cases and more than 80% of the deaths happen in the Africa, South of the Sahara. Africa suffers more than a million deaths, mostly children. * says his organization is supporting a study in Tanzania, to see if the new drug could be successfully used in Africa. Currently, in Africa, there are two first-line treatments with artesunate and other drugs. He says artesunate and mefloquine could have a use in place like Eastern Africa where there are high levels of resistance to several drugs. The Drugs for Neglected Diseases Initiative began in 2003. It was established by the * Institute and doctors without boarders along with 4 publicly supported research organizations. [´ËÌù×ÓÒѾ­±»×÷ÕßÓÚ2008-5-2 9:29:25±à¼­¹ý]

ÇÄÇÄ»° Íøµê ºÃÓÑ ÐÅÏ¢ Ìû×Ó¼¯ תÕÊ ÒýÓà »Ø¸´ ²¿Âä ÊÕ²Ø	µÚ10Â¥¡ø

Researchers tested the new medicine in a one year study of 17,000 patients in the state of Acre in the Brazilian Amazon. Health care resources in the area were also expended including early identification of malaria. Health official say the result was a 36% drug in cases. Malaria is caused by aprasid which is passed to humans through mosquito bites. As many as five hundred million infections haven every year. Around 60% of the cases and more than 80% of the death happen in Africa, South of the Sahara. Africa suffers more than a million death mostly children. Dutch Baku says his organization is supporting a study in Tanzania to see if the new drug could be successfully used in Africa. Currently in Africa, there are two first line treatments with artesunate and other drugs. He says artesunate and mefloquine could have a use in places like eastern Africa where there are high levels of resistance to several drugs. The drugs for neglected diseases initiative begin in 2003. It was established by the pass 10 institute and doctors without borders along with four publicly supported research organizations.

---------------------------------------------- µãȼ¼¤Ç飬´«µÝ˼Ïë (Light the Passion, Share the Idea)

ÇÄÇÄ»° Íøµê ºÃÓÑ ÐÅÏ¢ Ìû×Ó¼¯ תÕÊ ÒýÓà »Ø¸´ ²©¿Í ²¿Âä ÊÕ²Ø	µÚ11Â¥¡ø

Researchers tested the new medicine in a one-year study of seventeen thousand patients in the state of arcu in the Bazillian amazon. Health care resources in the areas were also expended including early identification of malaria. Health officials say the result was a sixty percent drop in cases. Malaria is caused by a parasite which is pass to human through mosquito bites. As many as five hundred million infections happen every year. Around sixty percent of the cases and more than eighty percent of the death happen in Arican ,south of Saharra. Africa suffers more than a billion death mostly chilren. B P says his organization is supporting a study in Tanzania to see if the new drug could be successfully used in Africa. Currently in Africa ,there are two first line treatments with P and other drugs. He says pacenat and malaquen could help a use in places like Eastern Europe where there are high levels of resistance to several drugs. The drugs for negaletive disease and initiative began in 2003. It was establised by the Paster Institute and Doctors without Borders along with four publicly supported research organizations

---------------------------------------------- ------------------------------------------- No pains, no gains.

ÇÄÇÄ»° Íøµê ºÃÓÑ ÐÅÏ¢ Ìû×Ó¼¯ תÕÊ ÒýÓà »Ø¸´ ²¿Âä ÊÕ²Ø	µÚ12Â¥¡ø

¸ÃÄÚÈÝÂ¥Ö÷²ÅÄÜä¯ÀÀ

ÇÄÇÄ»° Íøµê ºÃÓÑ ÐÅÏ¢ Ìû×Ó¼¯ תÕÊ ÒýÓà »Ø¸´ ²©¿Í ²¿Âä ÊÕ²Ø	µÚ13Â¥¡ø

¡¾Èý¶à195¡¿ Researchers tested the new medicine in a one year study of seventeen thousand patients in the state of x in the Brazilian x. Health care resources in the area were also expanded including early identification of malaria. Health officials say the result was a thirty-six percent drop in cases. Malaria is caused via a x which is passed to humans through x bites. As many as five hundred million infections happen every year. Around sixty percent of the cases and more than eighty percent of the deaths happen in Africa, south of the Sahara. Africa suffers more than a million deaths, mostly children. X says his organization is supporting a study in Tanzania to see if the new drug could be successfully used in Africa. Currently in Africa, there are two first-line treatments artesunate and other drugs. He says artesunate and mefloquine could have a use in places like Eastern Africa where there are high levels of resistance to several drugs. The drugs for neglected diseases x began in two thousand three. It was established by the X institute and doctors without boarders along with four public supported research organizations.

---------------------------------------------- ÎÒÄî×ÅÖ¥Â鿪ÃÅ£¬Óö¼ûÄÇЩ¶ÔµÄÈË¡­¡­

ÇÄÇÄ»° Íøµê ºÃÓÑ ÐÅÏ¢ Ìû×Ó¼¯ תÕÊ ÒýÓà »Ø¸´ ²©¿Í ²¿Âä ÊÕ²Ø	µÚ14Â¥¡ø

Èý¶à512 Researchers tested the new medicine in a one year¡¯s study of seventeen thousand patients in the state of brakui in the brazilian amazen . Health care resources in the area were also expended including early identification of malaria. Health official say the result was a 76% drugge incases. Malaria is caused by a parasite which is passed to humans by mosquito bites. As many as 500 million section happen every year. Around 60% of the cases and more than 80% of the death happen in Africa south of the sahara. African suffer more than a million death mostly children. Sach paycou says his organization is supporting a study in Tanzania see if the new drug could be successfully used in Africa. Currently in Africa there are two first line treatments which are artesunate and other drugs. He says artesunate and mefloquine could have a use in places like Eastern Africa where they are high levels of resistance to several drugs. The dugs for an elective diseases of initiative begin in 2003. it was established by the past institute and doctors without boileds along with four public supported research organizations

---------------------------------------------- ÃÔ»ó

ÇÄÇÄ»° Íøµê ºÃÓÑ ÐÅÏ¢ Ìû×Ó¼¯ תÕÊ ÒýÓà »Ø¸´ ²¿Âä ÊÕ²Ø	µÚ15Â¥¡ø

Researchers tested the new medicine in the one year study of seventeen thousand patients in the state of A*, in the B*, A*. Health care resources in the area were also expanded, including early identification of malaria. Health officials say the result was a thirty-six percent drop in cases. Malaria is caused by a parasite which is pass to humans through the * bites. As many as five hundred million infections happen every year. Around sixty percent of the cases and more than eighty percent of the death happen in Africa, south of the Sahara. Africa suffers more than a million death mostly children. * says his organization is supporting a study in Tanzania to see if the new drug could be successfully used in Africa. Currently, in Africa, there are two first-line treatments with artesunate and other drugs. He says artesunate and mefloquine could have a use in places like Eastern Africa with there are high levers of resistance to several drugs. The drugs for neglect diseases initiative began in two thousand three. It was established by the pastor institute and doctors without boards along with four publicly supported research organizations